DC Studios has a new contender on its hands. "Clayface," a horror-thriller take on the Batman rogue, opened in theaters on October 19 and arrives with a 7.4 rating on TMDb, giving the studio a potential box-office bright spot at a moment when the theatrical marketplace has been hungry for a win. Directed by James Watkins, the film runs 109 minutes and stars Tom Rhys Harries in the dual role of Matt Hagen and the monstrous figure he becomes.
The timing could hardly be better for DC, which has been searching for a commercially sturdy release to anchor its fall slate. "Clayface" carries a modest, genre-driven profile compared with the studio's tentpole ambitions, and that lower center of gravity may work in its favor: horror and thriller audiences have reliably turned out in recent seasons, and a well-reviewed villain origin story can travel far beyond the comic-book faithful. The early audience score suggests the film is connecting with viewers rather than merely coasting on brand recognition.
A Fall From Grace, Then Something Worse
The film traces Matt Hagen's improbable ascent from the streets of Gotham to Hollywood leading man, a rise that collapses when a local crime boss's actions leave him horrifically disfigured. Abandoned by his team and stripped of everything he built, Hagen pursues an experimental treatment that restores his former appearance - but the procedure also loosens his hold on reality, sending him down a path of all-consuming revenge.
That premise places "Clayface" squarely in the body-horror tradition while keeping one foot in the superhero sandbox. The genres listed for the film - horror, thriller and science fiction - signal a darker, more intimate register than the universe-building spectacles that usually define DC's output. Watkins, whose filmography leans toward tense, psychologically charged material, would seem a natural fit for a story about a man whose greatest enemy turns out to be his own fractured perception.
A Cast Built for Character Work
Harries leads a deep ensemble as Hagen and his transformed alter ego, supported by Naomi Ackie as Caitlyn Corr, Eddie Marsan as Frank Fitzpatrick, Max Minghella as John Borrelli, David Dencik as Marcos Jabo, Francesca Corney as Rosie, Ruby Sear as Theresa and Wil Coban as Bones. It is a cast weighted toward stage-trained British talent, and the presence of Marsan and Dencik in particular hints at a film that takes its criminal underworld seriously rather than treating it as set dressing.
For Harries, the part represents a substantial leading showcase in a Hollywood production. For DC Studios, the value is more strategic: a mid-budget, director-driven genre piece can generate returns without the marketing burden of a franchise tentpole, and a hit here would validate a broader approach of letting individual filmmakers put a distinct stamp on familiar characters.
The Wider Box Office Picture
"Clayface" enters a market where "You Can See Everything" remains a durable draw, holding strong weeks into its run and keeping the box office conversation focused on staying power rather than opening-weekend spikes. That film's continued performance gives the marketplace a stable floor, and "Clayface" now tests whether a darker, more niche DC title can carve out its own audience alongside it rather than competing for the same ticket buyers.
Early signals are encouraging. A 7.4 TMDb rating is a respectable figure for a genre release and points to word-of-mouth that could extend the film's commercial life past its debut. Horror-adjacent titles often post softer openings followed by durable runs when audiences respond, and the Halloween corridor offers a natural window for a film about a man whose face and mind both betray him.
The weeks ahead will reveal whether "Clayface" becomes the kind of lean, profitable win DC Studios needs - proof that smaller, stranger stories can carry their own weight - or a cult item that finds its audience later. Either way, the film's arrival marks a deliberate step away from the familiar playbook, and a studio betting on a disfigured leading man's descent into revenge is a studio willing to take a risk.
Source: The Hollywood Reporter
